COVID-19 Research Kits and Tools

COVID-19 is an acute respiratory syndrome caused by the SARS-CoV-2 virus. Vaccine and drug discovery scientists have focused on the therapeutic potential of the SARS-CoV-2 Spike protein and host cell proteins such as ACE-2. Scientists developing diagnostic tests are primarily interested in quantifying the SARS-CoV-2 spike and nucleocapsid proteins as well as measuring the host antibody response via Cytokine Storm, IgG/IgM, Neutralizing antibody levels. Assay Genie have launched a suite of reagents including activity assays, immunoassays, antibodies and proteins to help scientists optimize their workflows and research output in the fight against COVID-19.

Immunoassays

Assay Genie have a wide range of quantitative and qualitative highly validated and sensitive ELISA & multiplex immunoassays to measure SARS-CoV-2 antigens as well as host antibodies generated during the immune response.

  • Serology ELISA for IgG, IgM & Neutralizing Antibodies
  • ELISA to detect SARS-CoV-2 viral proteins
  • ELISA to detect Cytokine Storm
  • GeniePlex Multiplex Immunoassays for Cytokine Storm
  • ELISpot
  • Tocilizumab (Actemra) Monitoring ELISA

ACE2 & Host Cell Proteases

SARS-CoV-2 virus has been shown to use the ACE2 receptor in host cells to gain entry. Assay Genie have developed highly sensitive ACE-2 ELISA, activity and inhibitor assays to aid drug discovery and development. As SARS-CoV-2 is cleaved by a number of host cell proteases such as TMPRESS2, Assay Genie also have a range of proteins, antibodies and assays to help researchers investigate the process.

  • ACE2 ELISA, Inhibitor and Activity Assays
  • Host Cell Protease reagents for TMPRESS2, Furin, Cathepsin L (CTSL) Cathepsin B (CTSB), Neutrophil Elastase (ELA2)

SARS-CoV-2 Recombinant Proteins

Pure and active tagged and untagged SARS-CoV-2 viral proteins and host cell proteins for drug discovery, vaccine research and diagnostic kit development.

  • Spike
  • Spike Variants
  • Spike RBD
  • Spike Trimer
  • NSP
  • NP
  • ACE2
  • Host Cell Proteases

SARS-CoV-2 & Host Cell Antibodies

Highly validated polyclonal, monoclonal and recombinant antibodies against SARS-CoV-2 viral proteins, host cell proteins and antibodies.

  • Spike
  • RBD
  • Neutralizing
  • Nucleocapsid

PCR

A highly sensitive Triplex QPCR kit to detect SARS-CoV-2 in a variety of sample types.

Rapid Tests

Rapid antibody & neutralizing antibody tests to measure the immune response to COVID-19 infection as well as 15-minute rapid antigen tests for viral protein detection.

Swabs

Flocked swabs available with and without VTM (Viral Transport Media) for the collection and transport of SARS-CoV-2.

COVID-19 Research Kits and Tools

Intense research is now required to elucidate immunological & cardiovascular pathways involved in COVID-19. This research will help in development of a vaccine versus the SARS-CoV-2 virus and the development of therapeutics and anti-virals to prevent and/or repress SARS-CoV-2 infection. To support COVID-19 research we have developed some key biological research tools such as antibodies, recombinant proteins, ACE2 assays and multiplex panels to measure cytokine storm. You can find out more below or by contacting us here.

COVID-19 research tools - webinar